Collaboration - January 14, 2014
Cadila Pharmaceuticals ties up with NovaSAID for drug development
Cadila Pharmaceuticals on Monday announced a partnership with Swedish NovaSAID to develop innovative treatment for inflammation and pain management. The duo will develop new treatment for inflammation and pain in conditions such as rheumatoid arthritis. NovaSAID is a company in Karolinska Development’s portfolio. The companies will collaborate around pre-clinical and clinical development of drug candidates […]